Supernus Pharmaceuticals
SUPN
#4463
Rank
A$2.78 B
Marketcap
$49.81
Share price
0.99%
Change (1 day)
-4.76%
Change (1 year)

Operating Margin for Supernus Pharmaceuticals (SUPN)

Operating Margin as of March 2025 (TTM): 14.78%

According to Supernus Pharmaceuticals 's latest financial reports and stock price the company's current Operating Margin is 14.78%. At the end of 2024 the company had an Operating Margin of 14.79%.

Operating Margin history for Supernus Pharmaceuticals from 2011 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
202414.79%3144.52%
20230.46%-94.99%
20229.10%-27.87%
202112.62%-61.05%
202032.41%-13.7%
201937.55%9.54%
201834.28%2.98%
201733.29%42.1%
201623.43%136.46%
20159.91%-189.19%
2014-11.11%-98.55%
2013-767.73%-75.45%
2012-3,127.30%-36.38%
2011-4,915.32%-86.8%
2010-37,239.62%-341403.21%
200910.91%-102.9%
2008-376.67%-7.69%
2007-408.04%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
-259.55%-1,856.10%๐Ÿ‡บ๐Ÿ‡ธ USA
53.48% 261.84%๐Ÿ‡บ๐Ÿ‡ธ USA
28.15% 90.46%๐Ÿ‡บ๐Ÿ‡ธ USA
-17.34%-217.32%๐Ÿ‡บ๐Ÿ‡ธ USA
18.05% 22.12%๐Ÿ‡บ๐Ÿ‡ธ USA
18.78% 27.06%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.